Costs and Expenses 579.71 545.20 34.51 6.33 Profit (Loss) -Net 30.02 53.31 (23.29) (43.69) Income of Sale and Administration Transaction For the Year ended 31st December (Unit: Million Baht) Year Increase
. Administrative expenses For Quarter 2 of the year 2020, the administration expenses was 11.80 million baht or 11.70% from sale revenue compared to the same period last year at 12.34 million baht or 13.24% from
Administration Expense 63.31 16.4 45.08 17.9 18.22 40.4 Profit before finance costs and income tax 46.25 12.0 30.63 12.2 15.63 51.0 Finance costs (0.03) (0.0) (0.16) (0.1) 0.13 (78.9) Profit before tax 46.22 12.0
period of 2019. This increase was mainly due to switching towards more cost-effective marketing channels. Administrative Expenses In the 3rd Quarter of 2018 and 2019, administration costs increased from
Securities and Exchange Commission 3 Appendix Definitions “IT assets” means (1) system assets, i.e., computer network, system software, application software, and information systems; (2) equipment assets, i.e
Securities and Exchange Commission Appendix Definitions “ IT assets ” means (1) system assets, i.e., computer network, system software, application software, and information systems; (2) equipment assets, i.e
represents decreasing of 6 Million Baht (122%) from Q3/2017. The main cause for the lower net profit are occurred from increasing of selling and administration expenses, and loss on foreign exchange rates
Group The Group has principally engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical
principally engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which dialysis
Group The Group has principally engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical